MD-ZEROFOX
6.10.2020 15:02:14 CEST | Business Wire | Press release
ZeroFOX , the global leader in Digital Risk Protection, is proud to announce the acquisition of the Cyveillance business from LookingGlass Cyber Solutions, Inc™. The Cyveillance team has over 20 years of experience delivering comprehensive threat intelligence services, protecting the corporate brands, executives, and data of the world's largest and most respected financial services, energy, and public sector organizations. The combination of the ZeroFOX Artificial Intelligence-powered Digital Risk Protection Platform with Cyveillance’s comprehensive threat intelligence data lake and expansive human dark web intelligence capabilities positions ZeroFOX as the world leader in Digital Risk Protection, connecting automated protection and intelligence for organizations of all sizes.
“Our merger with the Cyveillance team fulfills our strategic vision of accelerating our position as the definitive worldwide leader in Digital Risk Protection,” said James C. Foster, CEO of ZeroFOX. “The addition of Cyveillance allows us to further scale our Digital Risk Protection services and expand our threat intelligence capabilities, complementing our renowned AI & remediation capabilities, to address the entire digital threat lifecycle. Our combined customer base and over 400 employees makes us the largest, most proven provider in the Digital Risk Protection market, serving the needs of the world’s most recognized brands.”
Organizations today operate in a world that demands a digital-first approach. The dramatic shift creates a global digital footprint and attack surface on social media, mobile applications, websites, and other external digital platforms. This unprotected public attack surface exposes organizations and their communities to targeted cyber-attacks, data loss, phishing scams, compliance violations, and account takeovers.
“ZeroFOX’s cyber platform powered by Artificial intelligence and Machine Learning is truly impressive. It was clear that we needed to bring these two organizations together to achieve scale overnight to benefit our customers,” said Gilman Louie, co-founder of Alsop Louie and Executive Chairman of LookingGlass Cyber Solutions. “Combined with the rich Cyveillance data, human and machine intelligence and expertise, our customers will now be fully equipped to combat growing digital threats and exert security control back into digital experiences. This new powerhouse company will enable customers to achieve a new level of protection that is unique in the industry. Foster has built a world-class team and I am excited to join it and the ZeroFOX Board of Directors.” Louie serves as the commissioner for the United States National Security Commission for Artificial Intelligence and Chairman of the Federation of American Scientists.
While the scale of threats targeting public platforms makes it difficult for security teams to create actionable intelligence and seek timely remediation, the combined power of the ZeroFOX Digital Risk Protection Platform and Cyveillance’s customer-centric Digital Risk Protection services will give customers unparalleled visibility, analysis, and remediation capabilities to prioritize and mitigate threats at internet scale and speed.
“Since 2005, I have been honored to be a member of the Cyveillance team. With decades of threat intelligence tradecraft experience and a state of the art 24x7 Cyber Security Center, Cyveillance brings a best-in-class data collection and vetting advantage over all other TI providers. This enriched Intelligence delivered within the ZeroFOX Platform will enable customers to achieve a new level of protection that is years ahead of the competition,” said James Carnall, Cyveillance General Manager. “I look forward to partnering with ZeroFOX to deliver timely, relevant and actionable threat intelligence. It’s clear that we will have the most robust Digital Risk Protection and Threat Intelligence portfolio available in the market.”
ZeroFOX will expand its service offerings for existing customers by leveraging the Cyveillance team, technology and their extensive collection of intelligence data. Existing Cyveillance customers will continue to receive custom Digital Risk Protection services and have access to the power of the ZeroFOX Digital Risk Protection Platform and its industry-leading remediation services.
Cyveillance capabilities include:
- Cyveillance Digital Risk Protection Services - A customer-centric Digital Risk Protection managed service that augments the force of information security teams looking to identify, analyze, and disrupt threats to critical assets and data.
- Cyveillance Data Lake - Cyveillance has the world's largest repository of cyber threat intelligence and threat actor information with more than 20 years of data assembled from the surface, deep, and dark web—powering enrichment, contextualization, API feeds, and threat hunting.
- Cyveillance Finished Intelligence - A digital library of actionable and relevant finished intelligence based on primary threat research and a proprietary intelligence data lake.
- Cyveillance Investigation, Analysis and Response Services - Custom investigation and analysis for physical and digital threats. Advanced analysts provide deep-dive reports, security forensics, threat assessments, research projects, and ad-hoc analyst projects. Projects are designed to dynamically apply and incorporate industry best practices into security and risk management programs.
As part of the acquisition, ZeroFOX will continue to exhibit leadership in this new cybersecurity era by establishing a world-class Cybersecurity Center of Excellence in the Washington, D.C., Metro Area with major offices in Reston, Virginia, and Baltimore, Maryland. This includes a state-of-the-art Cybersecurity Operations Center and Executive Briefing facility for demonstrating and leading organizations on cybersecurity trends, best practices, and technology innovations for Digital Risk Protection. ZeroFOX will also continue to grow its Centers of Excellence in the United Kingdom, Latin America, Asia and the Middle East with a focus on security operations and R&D.
ZeroFOX is trusted by global enterprises, serving thousands of customers, including more than 350 financial institutions in every major country. Funding by Intel Capital, NEA, Highland Capital Partners, Redline Capital Management, Hercules Capital, Comcast Ventures, and Core Capital, ZeroFOX has raised over $150 million in funding to date.
About ZeroFOX - ZeroFOX, the global category leader in Digital Risk Protection, safeguards modern organizations from dynamic security risks across the public attack surface including social media, mobile application, surface, deep and dark web, email and domains, and digital collaboration platforms. With complete global coverage and an artificial intelligence-based analysis engine, the ZeroFOX Platform identifies and remediates targeted phishing attacks, credential compromise, data exfiltration, brand hijacking, executive and location threats, and more. The patented ZeroFOX Platform technology processes and protects millions of posts, messages, and accounts daily across the social and digital landscape, spanning LinkedIn, Facebook, Slack, Instagram, Pastebin, YouTube, mobile app stores, domains, cloud-based email, and more.
About Cyveillance - Cyveillance, which was acquired by LookingGlass in 2015, has a rich history of providing customer-centric threat intelligence services to protect the most critical assets of enterprises worldwide. Founded in 1997, Cyveillance delivers an open source intelligence-led approach to security through continuous, comprehensive monitoring and analysis of millions of online data sources to protect client information, infrastructure, and employees from physical and online threats.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201006005690/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press release
REACH study met its first primary endpoint, showing that Broncho‑Vaxom® (OM‑85) was associated with a 28-38% reduction in respiratory tract infection rates at 12 months and 29-41% reduction at 24 months, comparing post-treatment versus pre-treatment initiation.1 The reduction was observed regardless of the frequency of respiratory tract infections in the previous year (1-3, >3) and across age subgroups (1-5, 6-11, 12-17, 18-64, >64 years).1 By reflecting everyday clinical practice and capturing episodes that necessitated a visit to the doctor, these extensive data offer critical new evidence of the therapy’s long-term relevance for patients suffering from recurrent respiratory tract infections. Evaluating a vast cohort of more than 15,790 paediatric, adolescent, adult and elderly patients in China, Italy, and Belgium, REACH represents the largest and only multi-country real-world evidence study to date for Broncho-Vaxom®.1,2 The study cohort includes patients with different co-morbidit
Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press release
In myelofibrosis (MF), INCA033989 delivered rapid and durable clinical benefits including meaningful spleen volume reductions, symptom improvement and anemia responses, both as a monotherapy and in combination with ruxolitinibIn essential thrombocythemia (ET), 87% of patients achieved a hematologic response, including 70% complete responses; responses were rapid (median ~2 weeks to a durable complete hematologic response) and durable (median response duration of 23 weeks)Across MF and ET, INCA033989 consistently reduced mutant CALR (mutCALR) variant allele frequency (VAF) in most evaluable patients, with reductions correlating with clinical responses and supporting its potential for disease modificationFirst-in-class mutCALR-targeted antibody shows potential to modify disease biology in both MF and ETINCA033989 demonstrated a favorable and manageable safety profile with no dose-limiting toxicities, with most patients with MF and ET continuing treatment Incyte (Nasdaq:INCY) today announ
Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press release
- frontMIND study evaluating tafasitamab (Monjuvi®/Minjuvi®) in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL) selected for the prestigious Plenary Abstracts Session at EHA 2026 - Results showed tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) significantly prolonged progression-free survival (PFS), reducing risk of disease progression or death by 25% - Positive trends toward PFS benefit with Tafa-Len-R-CHOP were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypes - The frontMIND data support global regulatory applications for tafasitamab and lenalidomide in addition to R-CHOP for previously untreated DLBCL and HGBL Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified c
Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press release
Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til
IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 18:36:00 CEST | Press release
Venneman brings more than 30 years of digital transformation, AI, and enterprise technology experience as IQM prepares for its planned Nasdaq listing IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
